255 related articles for article (PubMed ID: 3162051)
21. [Evaluation of the assay for alpha 2PI and alpha 2PI-plasmin complex using the one-step sandwich method (EIA)].
Aoki N; Takenaga T; Hasegawa H; Oguma Y; Kobayashi N; Sakata Y; Fujimaki M; Ikematsu S; Kuroso K; Matsuda T
Rinsho Byori; 1987 Nov; 35(11):1275-81. PubMed ID: 2965268
[No Abstract] [Full Text] [Related]
22. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
23. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
Itoh N
Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
[No Abstract] [Full Text] [Related]
24. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
Kawai Y; Watanabe K
Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
[No Abstract] [Full Text] [Related]
25. [Diagnosis of DIC based on evidence].
Wada H; Nishioka J; Nobori T; Sakaguchi A; Abe Y
Rinsho Byori; 2006 Nov; 54(11):1172-7. PubMed ID: 17240840
[TBL] [Abstract][Full Text] [Related]
26. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
28. Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
Koseki M; Asada N; Uryu H; Takeuchi M; Asakura H; Matsue K
Int J Hematol; 2007 Dec; 86(5):403-6. PubMed ID: 18192107
[TBL] [Abstract][Full Text] [Related]
29. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
30. Activation of intravascular coagulation in Bell's palsy.
Omori H; Ikeda M; Kukimoto N; Kawamoto H; Ikui A; Tomita H
Eur Arch Otorhinolaryngol; 1994 Dec; ():S471-2. PubMed ID: 10774425
[No Abstract] [Full Text] [Related]
31. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
32. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
Iijima K
Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
[No Abstract] [Full Text] [Related]
33. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
Asakura H; Wada H; Okamoto K; Iba T; Uchiyama T; Eguchi Y; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S
Thromb Haemost; 2006 Feb; 95(2):282-7. PubMed ID: 16493490
[TBL] [Abstract][Full Text] [Related]
34. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
35. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
[TBL] [Abstract][Full Text] [Related]
36. Plasma thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus.
Kawakami M; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishii H; Kazama M; Kawagoe M; Nakamura H
J Rheumatol; 1992 Nov; 19(11):1704-9. PubMed ID: 1337109
[TBL] [Abstract][Full Text] [Related]
37. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
38. [Prevention and early diagnosis of disseminated intravascular coagulation].
Matsuda T
Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1375-82. PubMed ID: 8245630
[No Abstract] [Full Text] [Related]
39. [The significance of measurement of alpha 2PI-plasmin complex in acute promyelocytic leukemia].
Asakura H; Itoh K; Johkaji Y; Saito M; Uotani C; Kumabashiri I; Matsuda T
Rinsho Ketsueki; 1988 Apr; 29(4):534-8. PubMed ID: 2969985
[No Abstract] [Full Text] [Related]
40. [Alpha 2-plasmin inhibitor plasmin complex in patients undergone surgery in femoral neck fracture].
Takahashi Y; Kihara K; Saitoh J; Murai Y; Mori M
Rinsho Byori; 1990 Feb; 38(2):208-12. PubMed ID: 2139477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]